CANNABİS USE DİSORDER, SYNTHETİC CANNABİNOİD AND AMOTİVATİONAL SYNDROME: A CASE REPORT
Keywords:
Cannabis use disorder, amo-tivational syndrome, synthetic cannabinoidAbstract
Cannabis is one of the most widely used substances in the world and it can lead to many well-known psychiatric symptoms and disorders. However, cannabis-related amotivational syndrome cases are less known. In this report, a case of an amoti-vational syndrome caused by chronic cannabis use, who switched to synthetic cannabinoids after developing the syndrome, is presented. The awareness of this syndrome in cannabis use disorder is important in terms of function losses, low treatment motivation and compliance are considered.
References
Ögel K. Epidemiology of substance use disorders. Turkiye Klinikleri J Int Med Sci 2005; 1: 61-64.
Arı M, Şahpolat M, Kokaçya MH, Çöpoğlu ÜS. A motivational syndrome: less known and diagnosed as a clinical. Journal of Mood Disorders 2015; 5: 31-35.
Reilly D, Didcott P, Swift W, Hall W. Long-term cannabis use: characteristics of users in an Australian rural area. Addict 1998; 93: 837-846.
Leweke FM, Koethe D. Cannabis and psychiatric disorders: it is not only addiction. Addict Biol 2008; 13: 264-275.
Ozaki S, Wada K. A motivational syndrome in organic solvent abusers. Folia Pharmacol Jpn 2001; 117: 42-48.
Howlett AC, Breivogel CS, Childers SR, et al. Cannabinoid physiology and pharmacology: 30years of progress. Neuropharmacol 2004; 47: 345-358.
van Hell HH, Vink M, Ossewaarde L, et al. Chronic effects of cannabis use on the human reward system: an fMRI study. Eur Neuropsychopharmacol 2010; 20: 153-163.
Rovai L, Maremmani AG, Pacini M, et al. Negative dimension in psychiatry. A motivational syndrome as a paradigm of negative symptoms in substance abuse. Riv Psichiatry 2013; 48:1-9.
Bloomfield MAP, Morgan CJ, Egerton A, et al. Dopaminergic function in cannabis users and its relationship to cannabis-induced psychotic symptoms. Biol Psychiatry 2014;75: 470-478.
McGlothlin WH, West LJ. The marijuana problem: an overview. Am J Psychiatry 1968; 125: 370-378.
Maugh TH. Marihuana: Does it damage the brain. Science 1974; 175: 775–776.
Creason CR, Goldman M. Varying levels of marijuana use by adolescents and the amotivation-al syndrome. Psychol Rep 1981; 48: 447-454.
Stokes PR, Egerton A, Watson B, et al. History of cannabis use is not associated with alterations in striatal dopamine D2/D3 receptor availability. J Psychopharmacol 2012; 26: 144-149.
Urban NB, Slifstein M, Thompson JL, et al. Dopamine release in chronic cannabis users: A [11C] raclopride positron emission tomography study. Biol Psychiatry 2012; 71: 677-683.
Bozkurt M, Umut G, Evren C, Karabulut V. Sentetik kannabinoid kullanımı nedeniyle polikliniğe başvuran hastaların klinik özellikleri ve laboratuvar sonuçları. Düşünen Adam Psikiyatri ve Nörolojik Bilimler Dergisi 2014; 27: 328-334.
Kızıl ETÖ. Basit şizofeni. Klinik Psikiyatri Dergisi 2006; 9 :82-88.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Journal of Dependence
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
...